BIOPHARMA: Biopharmaceutical Products in the U.S. and European Markets, 10th edition

BIOPHARMA^®: Biopharmaceutical Products in the U.S. and European Markets

The only information resource (database, formerly multi-volume book) concerning biopharmaceutical products! The Biosimilars/Biobetters Reference Products Reference

Encyclopedic monographs concentrate on products' biotechnology and commercial aspects
Includes all biopharmaceuticals - recombinant and other proteins, monoclonal antibodies, vaccines, enzymes, blood products, radioimmune conjugates, cultured cells and tissues
More than a directory - Besides detailed descriptions and indexing, includes competitive, technological and regulatory intelligence/assessments and much unique and hard-to-find information.
Full text Web database subscriptions available at reasonable rates for individuals (by password) and organizations (by I.P. nos.)
New! Analysis of 2011 FDA Biopharmaceutical Approvals

Quick tour: Description Reviews Product database Company database Order

The Bottom line -- If you have an interest in biopharmaceuticals, whether innovative or biosimilars/biobetters/biogenerics, the BIOPHARMA Web database is an essential, must-have information resource! As the only information resource/reference concerning biopharmaceutical products, BIOPHARMA defines the common denominator for information concerning biopharmaceuticals (what others have and know, but you are missing by not being a subscriber). BIOPHARMA is by far the best single information source concerning biopharmaceutical products, particularly their biotechnology and commercial aspects. The database provides much high value, even invaluable, information, including information retrievable nowhere else; has excellent reviews; and is a bargain by pharmaceutical information standards and compared to alternatives (either doing without or spending much more time and/or money just to retrieve bits and pieces of information about these products and companies). Now in its 11th year/edition, BIOPHARMA provides you with the fruits of over ~3.5 man-years of effort, including intensive daily tracking, searching and collating of news and information.
Authored by a single individual, BIOPHARMA provides a level of consistency in presentation, indexing, etc. not found in most other pharmaceutical/biotech information resources. But with the database being a massive work, >1.3 million words, well over 2,000 dense pages if printed, authorship by an individual has its limitations. For example, over time monographs generally have new information added rather than being totally rewritten.

Description/Flyer; Order form

Reviews - reviews from industry, scientific, professional association and library publications

Web Databases
Products:
Companies:
Password

Free Public Databases! View portions of monographs and indexing; extensive search capabilities
Web database subscriptions - Full access for individuals and organizations

Sample Full Product Monographs - full entries from the database - Want to see more? Request a trial database password.
- Carboxypeptidase, rDNA (Voraxaze from Protherics - not yet approved)
Indexes: (These are static lists. It is always best to search the database.)
- Companies, Company Role, State/Country and Marketing Territory Indexes
From the last printed book version (6th edition, 2007; then 2 vol., 1603 pages; now much bigger): Coverage; User's Guide (PDF); Table of Contents (PDF)]
About the Author & Publisher and his company, the Biotechnology Information Institute
New! Analysis of 2011 FDA Biopharmaceutical Approvals
Related Web sites: FDA Biopharmaceutical Approvals; BIOSIMILARS.com; U.S. BIOPHARMACOPEIA Registry of Biopharmaceutical Products

Contact the Author/Publisher:

Ronald A. Rader

Biotechnology Information Institute
1700 Rockville Pike, Suite 400
Rockville, MD 20852

E-Mail: biotech@biopharma.com
Phone: 301-424-0255 (9AM-5PM, Eastern U.S.)

BIOPHARMA®: Biopharmaceutical Products in the U.S. and European Markets

BIOPHARMA^®: Biopharmaceutical Products in the U.S. and European Markets